BioCatch vs Detect Technologies

BioCatch has a disclosed valuation of $1B, while Detect Technologies's valuation is not publicly available, making a direct size comparison difficult. BioCatch employs 100-500 people.

BioCatch has raised more in total funding at $213M, compared to Detect Technologies's $26M — a gap of $187M.

BioCatch holds the higher Awaira Score at 80/100, compared to Detect Technologies's 63/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 17-point gap that reflects meaningful differences in scale or traction.

BioCatch was founded by Avi Turgeman in 2011. Detect Technologies was founded by Harikrishnan Nair in 2017. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. Detect Technologies: Detect Technologies builds industrial AI safety and asset integrity solutions for oil and gas, chemicals, and manufacturing industries, using computer vision, drone inspection, and AI analytics to detect equipment anomalies, process safety deviations, and structural defects before they escalate into incidents. The platform replaces periodic manual inspection regimes with continuous AI-powered monitoring that identifies corrosion, leaks, and process parameter deviations in real time.\n\nThe company raised approximately $26M in Series B funding from investors including Accel and Envisioning Partners, and has deployed its T-Pulse and UltraVision products at major refineries, petrochemical complexes, and power plants in India, the Middle East, and North America. Detect Technologies has established commercial partnerships with major global oil and gas companies.\n\nIndustrial process safety is a domain where the consequences of failure are severe and the cost of preventive monitoring is justified by both regulatory requirements and avoided incident losses. Detect Technologies' AI-powered continuous monitoring approach addresses a fundamental limitation of traditional periodic inspection — the inability to detect developing problems between inspection cycles.

BioCatch was founded first in 2011, giving it 6 years of additional market experience. Detect Technologies was founded later in 2017. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.

BioCatch has approximately 100-500 employees, while Detect Technologies has approximately 50-200. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.

Yes, BioCatch and Detect Technologies are direct competitors — both operate in the AI Security space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.